Global Laser BPH Devices Market is valued at approximately USD 460.3 million in 2021 and is anticipated to grow with a healthy growth rate of more than 5.2% over the forecast period 2022-2029. Laser BPH Devices refer to medical devices used for treatment of Benign prostatic hyperplasia (BPH). Benign prostatic hyperplasia (BPH), also called enlargement of the prostate gland is a common health problem that affects elder adults. Its symptoms include blocking urine flow from the bladder because of an enlarged prostate gland. It also results in issues with the kidneys, bladder, as well as urinary system. Although the intensity of symptoms varies among those with enlarged prostate glands, and largely get worse over time. The increasing incidence of benign prostatic hyperplasia (BPH) and growing geriatric population are key factors driving the market growth.

The rising number of geriatric individuals is contributing towards the growth of the Global Laser BPH Devices market, as aging individuals are at high risk of developing benign prostatic hyperplasia (BPH). For instance - according to the World Bank Group, the world’s old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. Furthermore, as per World Economic Forum (WEF) estimates – as of 2019, in Japan around one-third population is over 65, and around 2.3 billion people are in their 70s. Also, rising preference towards minimally invasive procedures and growing healthcare infrastructure in developing regions would create a lucrative growth prospectus for the market over the forecast period. However, the high cost of Laser BPH Devices stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Laser BPH Devices Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the presence of leading market players as well as rise in the number of individuals suffering from benign prostatic hyperplasia. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and growing healthcare infrastructure in the region.

Major market players included in this report are:
Boston Scientific Corporation
OmniGuide
Metrum Cryoflex
Richard Wolf GmbH
Coloplast
Biolitec AG
Agiliti Health, Inc.
HealthTronics, Inc.
Endo Pharmaceuticals Inc.
Teleflex Incorporated

Recent Developments in the Market:
? In July 2020, Lumenis Ltd., one of the leading medical device companies for aesthetic, surgical and ophthalmic applications, launched its new MOSES 2.0, platform for urology care. This new platform demonstrates up to 85% greater stone ablation in lithotripsy procedures and same-day discharge, and also offers catheter-free procedures for BPH.


Global Laser BPH Devices Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, procedure, End-User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type
Holmium laser
Thulium laser
Green light laser
Others

By Procedure
Photoselective Vaporisation of the Prostate
Holmium laser ablation of the prostate

By End User
Hospitals
Clinics
Others


By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World